Marshall Wace
CLBT icon

Marshall Wace’s Cellebrite CLBT Stock Holding History

Marshall Wace’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-146,904
Closed -$2.02M – 3228
2026
Q1 		$2.02M Sell
146,904
-184,726
-56% -$2.78M ﹤0.01% 1778
2025
Q4 		$5.98M Sell
331,630
-746,208
-69% -$13.4M 0.01% 1074
2025
Q3 		$20M Buy
1,077,838
+798,337
+286% +$12.5M 0.02% 654
2025
Q2 		$4.47M Buy
+279,501
New +$4.98M 0.01% 1195
2024
Q4 		– Sell
-26,548
Closed -$447K – 2617
2024
Q3 		$447K Sell
26,548
-955,500
-97% -$14.2M ﹤0.01% 1960
2024
Q2 		$11.7M Sell
982,048
-253,095
-20% -$2.83M 0.02% 664
2024
Q1 		$13.7M Buy
1,235,143
+336,286
+37% +$3.43M 0.02% 640
2023
Q4 		$7.78M Buy
898,857
+401,454
+81% +$3.12M 0.01% 757
2023
Q3 		$3.81M Buy
497,403
+458,889
+1,191% +$3.44M 0.01% 974
2023
Q2 		$277K Buy
+38,514
New +$225K ﹤0.01% 2163

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Marshall Wace's CLBT Position: Q2 2026 in Review

Marshall Wace sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 146,904 shares — an estimated $2.02M sold.

Marshall Wace first reported a position in CLBT in Q2 2023 and held it in 10 quarters. The position peaked at $20M in Q3 2025. 200 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Marshall Wace reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Marshall Wace sold 146,904 Cellebrite shares in Q2 2026, an estimated $2.02M.
  • Marshall Wace first reported a position in Cellebrite in Q2 2023 and held it in 10 quarters.
  • Marshall Wace's Cellebrite position peaked at $20M in Q3 2025.
  • 200 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.